Results 171 to 180 of about 3,463,529 (362)

CHEMICAL TECHNOLOGY DIVISION, UNIT OPERATIONS SECTION MONTHLY PROGRESS REPORT, FEBRUARY 1962 [PDF]

open access: green, 1962
M.E. Whatley   +5 more
openalex   +1 more source

THE LICENSING DILEMMA: UNDERSTANDING THE DETERMINANTS OF THE RATE OF LICENSING [PDF]

open access: yes
Licensing entails a tradeoff: licensing payments net of transaction costs (revenue effect) have to be balanced against the lower price-cost margin and/or reduced market share that the increased competition (profit dissipation effect) from the licensee ...
Andrea Fosfuri
core  

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

open access: yesMolecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim   +11 more
wiley   +1 more source

XII International scientific-technical conference «High chemical technologies-2008»

open access: yesТонкие химические технологии, 2008
XII International scientific-technical conference is devoted to problems of: chemistry and technology of organic and inorganic materials, chemistry and technology medical products and biologically active substances, ecological and economic problems of ...
V. D. Yulovskaya, V. S. Timofeev
doaj  

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

open access: yesMolecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez   +5 more
wiley   +1 more source

Machine learning for identifying liver and pancreas cancers through comprehensive serum glycopeptide spectra analysis: a case‐control study

open access: yesMolecular Oncology, EarlyView.
This study presents a novel AI‐based diagnostic approach—comprehensive serum glycopeptide spectra analysis (CSGSA)—that integrates tumor markers and enriched glycopeptides from serum. Using a neural network model, this method accurately distinguishes liver and pancreatic cancers from healthy individuals.
Motoyuki Kohjima   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy